Volume 12, Issue 2 (2-2014)                   IJRM 2014, 12(2): 103-110 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fanaei H, Khayat S, Halvaei I, Ramezani V, Azizi Y, Kasaeian A, et al . Effects of ascorbic acid on sperm motility, viability, acrosome reaction and DNA integrity in teratozoospermic samples. IJRM 2014; 12 (2) :103-110
URL: http://ijrm.ir/article-1-510-en.html
1- Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran , fanaei@razi.tums.ac.ir
2- Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
3- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4- Department of Pharmaceutics, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
5- Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
6- Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
7- Prof. Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
8- Kashan University of Medical Sciences, Kashan, Iran
Abstract:   (3477 Views)
Background: Oxidative stress in teratozoospermic semen samples caused poor assisted reproductive techniques (ART) outcomes. Among antioxidants, ascorbic acid is a naturally occurring free radical scavenger and as such its presence assists various other mechanisms in decreasing numerous disruptive free radical processes.
Objective: The main goal of this study was to evaluate potential protective effects of ascorbic acid supplementation during in vitro culture of teratozoospermic specimens.
Materials and Methods: Teratozoospermic semen samples that collected from 15 volunteers were processed, centrifuged and incubated at 37PoPC until sperm swimmed-up. Supernatant was divided into four groups and incubated at 37PoPC for one hour under different experimental conditions: Control, 10 μm A23187, 600μm ascorbic acid and 10 μm A23187+600 μm ascorbic acid. After incubation sperm motility, viability, acrosome reaction, DNA damage and malondialdehyde levels were evaluated.
Results: Our results indicated that after one hour incubation, ascorbic acid significantly reduced malondialdehyde level in ascorbic acid group (1.4±0.11 nmol/ml) compared to control group (1.58±0.13 nmol/ml) (p<0.001). At the end of incubation, progressive motility and viability in ascorbic acid group (64.5±8.8% and 80.3±6.4%, respectively) were significantly (p<0.05 and p<0.001, respectively) higher than the control group (54.5±6.8% and 70.9±7.3%, respectively). A23187 significantly (p<0.0001) increased acrosome reaction in A23187 group (37.3±5.6%) compared to control group (8.5±3.2%) and this effect of A23187 attenuated by ascorbic acid in ascorbic acid+A23187 group (17.2±4.4%). DNA fragmentation in ascorbic acid group (20±4.1%) was significantly (p<0.001) lower than controls (28.9±4.6%).
Conclusion: In vitro ascorbic acid supplementation during teratozoospermic semen processing for ART could protect teratozoospermic specimens against oxidative stress, and it could improve ART outcome.
Full-Text [PDF 226 kb]   (987 Downloads) |   |   Full-Text (HTML)  (468 Views)  
Type of Study: Original Article |

References
1. Keshtgar S, Fanaei H, Bahmanpour S, Azad F, Ghannadi A, Kazeroni M. In vitro effects of alpha-tocopherol on teratozoospermic semen samples. Andrologia 2012; 44 (Suppl.): 721-727. [DOI:10.1111/j.1439-0272.2011.01256.x]
2. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001; 345: 1388-1393. [DOI:10.1056/NEJMoa003005]
3. Agarwal A, Said TM. Oxidative stress, DNA damage and apoptosis in male infertility: a clinical approach. BJU Int 2005; 95: 503-507. [DOI:10.1111/j.1464-410X.2005.05328.x]
4. Brahem S, Elghezal H, Ghedir H, Landolsi H, Amara A, Ibala S, et al. Cytogenetic and molecular aspects of absolute teratozoospermia: comparison between polymorphic and monomorphic forms. Urology 2011; 78: 1313-1319. [DOI:10.1016/j.urology.2011.08.064]
5. Lu JC, Huang YF, Lu NQ. [WHO Laboratory Manual for the Examination and Processing of Human Semen: its applicability to andrology laboratories in China]. Zhonghua Nan Ke Xue 2010; 16: 867-871. (In Chinese)
6. Brahem S, Mehdi M, Elghezal H, Saad A. Detection of DNA fragmentation and meiotic segregation in human with isolated teratozoospermia. J Assist Reprod Genet 2011; 28: 41-48. [DOI:10.1007/s10815-010-9482-8]
7. Berger DS, Abdelhafez F, Russell H, Goldfarb J, Desai N. Severe teratozoospermia and its influence on pronuclear morphology, embryonic cleavage and compaction. Reprod Biol Endocrinol 2011; 9: 37. [DOI:10.1186/1477-7827-9-37]
8. Desai N, AbdelHafez F, Sabanegh E, Goldfarb J. Paternal effect on genomic activation, clinical pregnancy and live birth rate after ICSI with cryopreserved epididymal versus testicular spermatozoa. Reprod Biol Endocrinol 2009; 7: 142. [DOI:10.1186/1477-7827-7-142]
9. Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J, et al. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod 2007; 22: 174-179. [DOI:10.1093/humrep/del326]
10. Muratori M, Piomboni P, Baldi E, Filimberti E, Pecchioli P, Moretti E, et al. Functional and ultrastructural features of DNA-fragmented human sperm. J Androl 2000; 21: 903-912.
11. Szczygiel M, Kurpisz M. Teratozoospermia and its effect on male fertility potential. Andrologia 1999; 31: 63-75. [DOI:10.1111/j.1439-0272.1999.tb02848.x]
12. Lin YH, Wang YY, Chen HI, Kuo YC, Chiou YW, Lin HH, et al. SEPTIN12 genetic variants confer susceptibility to teratozoospermia. PLoS One 2012; 7: e34011. [DOI:10.1371/journal.pone.0034011]
13. Lu YH, Gao HJ, Li BJ, Zheng YM, Ye YH, Qian YL, et al. Different sperm sources and parameters can influence intracytoplasmic sperm injection outcomes before embryo implantation. J Zhejiang Univ Sci B 2012; 13: 1-10. [DOI:10.1631/jzus.B1100216]
14. Knez K, Tomazevic T, Zorn B, Vrtacnik-Bokal E, Virant-Klun I. Intracytoplasmic morphologically selected sperm injection improves development and quality of preimplantation embryos in teratozoospermia patients. Reprod Biomed Online 2012; 25: 168-179. [DOI:10.1016/j.rbmo.2012.03.011]
15. Ghani E, Keshtgar S, Habibagahi M, Ghannadi A, Kazeroni M. Expression of NOX5 in human teratozoospermia compared to normozoospermia. Andrologia 2013; 45: 351-356. [DOI:10.1111/and.12023]
16. Fanaei H, Keshtgar S, Bahmanpour S, Ghannadi A, Kazeroni M. Beneficial effects of alpha-tocopherol against intracellular calcium overload in human sperm. Reprod Sci 2011; 18: 978-982. [DOI:10.1177/1933719111401656]
17. Aitken R, De Iuliis G, Gibb Z, Baker M. The simmet lecture: new horizons on an old landscape- oxidative stress, DNA damage and apoptosis in the male germ line. Reprod Domest Anim 2012; 47 (Suppl.): 7-14. [DOI:10.1111/j.1439-0531.2012.02049.x]
18. Agarwal A, Prabakaran SA, Said TM. Prevention of oxidative stress injury to sperm. J Androl 2005; 26: 654-660. [DOI:10.2164/jandrol.05016]
19. Agarwal A, Sekhon LH. The role of antioxidant therapy in the treatment of male infertility. Hum Fertil 2010; 13: 217-225. [DOI:10.3109/14647273.2010.532279]
20. Lombardo F, Sansone A, Romanelli F, Paoli D, Gandini L, Lenzi A. The role of antioxidant therapy in the treatment of male infertility: an overview. Asian J Androl 2011; 13: 690-697. [DOI:10.1038/aja.2010.183]
21. Hu JH, Tian WQ, Zhao XL, Zan LS, Wang H, Li QW, et al. The cryoprotective effects of ascorbic acid supplementation on bovine semen quality. Anim Reprod Sci 2010; 121: 72-77. [DOI:10.1016/j.anireprosci.2010.04.180]
22. Ogli SA, Enyikwola O, Odeh SO. Evaluation of the efficacy of separate oral supplements compared with the combined oral supplements of vitamins C and E on sperm motility in Wistar rats. Nigerian J Physiol Sci 2009; 24: 129-135.
23. Memon AA, Wahid H, Rosnina Y, Goh YM, Ebrahimi M, Nadia FM. Effect of ascorbic acid concentrations, methods of cooling and freezing on Boer goat semen cryopreservation. Reprod Domest Anim 2013; 48: 325-330. [DOI:10.1111/j.1439-0531.2012.02155.x]
24. Ben Abdallah F, Fetoui H, Zribi N, Fakfakh F, Ammar-Keskes L. Antioxidant supplementations in vitro improve rat sperm parameters and enhance antioxidant enzyme activities against dimethoate-induced sperm damages. Andrologia 2012; 44 (Suppl.): 272-279. [DOI:10.1111/j.1439-0272.2011.01177.x]
25. Zini A, Al-Hathal N. Antioxidant therapy in male infertility: fact or fiction? Asian J Androl 2011; 13: 374-381. [DOI:10.1038/aja.2010.182]
26. Abad C, Amengual MJ, Gosalvez J, Coward K, Hannaoui N, Benet J, et al. Effects of oral antioxidant treatment upon the dynamics of human sperm DNA fragmentation and subpopulations of sperm with highly degraded DNA. Andrologia 2013; 45: 211-216. [DOI:10.1111/and.12003]
27. Hsieh YY, Chang CC, Lin CS. Seminal malondialdehyde concentration but not glutathione peroxidase activity is negatively correlated with seminal concentration and motility. Int J Biol Sci 2006; 2: 23-29. [DOI:10.7150/ijbs.2.23]
28. Roghani M, Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology 2010; 17: 55-59. [DOI:10.1016/j.pathophys.2009.07.004]
29. Aitken RJ. Sperm function tests and fertility. Int J Androl 2006; 29: 69-75. [DOI:10.1111/j.1365-2605.2005.00630.x]
30. Sukcharoen N, Keith J, Irvine DS, Aitken RJ. Predicting the fertilizing potential of human sperm suspensions in vitro: importance of sperm morphology and leukocyte contamination. Fertil Steril 1995; 63: 1293-1300. [DOI:10.1016/S0015-0282(16)57614-6]
31. Cocuzza M, Sikka SC, Athayde KS, Agarwal A. Clinical relevance of oxidative stress and sperm chromatin damage in male infertility: an evidence based analysis. Int Braz J Urol 2007; 33: 603-621. [DOI:10.1590/S1677-55382007000500002]
32. Desai N, Sharma R, Makker K, Sabanegh E, Agarwal A. Physiologic and pathologic levels of reactive oxygen species in neat semen of infertile men. Fertil Steril 2009; 92: 1626-1631. [DOI:10.1016/j.fertnstert.2008.08.109]
33. Koziorowska-Gilun M, Koziorowski M, Fraser L, Strzezek J. Antioxidant defence system of boar cauda epididymidal spermatozoa and reproductive tract fluids. Reprod Domest Anim 2011; 46: 527- 533. [DOI:10.1111/j.1439-0531.2010.01701.x]
34. Song GJ, Norkus EP, Lewis V. Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int J Androl 2006; 29: 569-575. [DOI:10.1111/j.1365-2605.2006.00700.x]
35. Colagar AH, Marzony ET. Ascorbic Acid in human seminal plasma: determination and its relationship to sperm quality. J Clin Biochem Nutr 2009; 45: 144-149. [DOI:10.3164/jcbn.08-251]
36. Fernandes GS, Fernandez CD, Campos KE, Damasceno DC, Anselmo-Franci JA, Kempinas WD. Vitamin C partially attenuates male reproductive deficits in hyperglycemic rats. Reprod Biol Endocrinol 2011; 9: 100. [DOI:10.1186/1477-7827-9-100]
37. Aziz N, Saleh RA, Sharma RK, Lewis-Jones I, Esfandiari N, Thomas AJ Jr, et al. Novel association between sperm reactive oxygen species production, sperm morphological defects, and the sperm deformity index. Fertil Steril 2004; 81: 349-354. [DOI:10.1016/j.fertnstert.2003.06.026]
38. Khosrowbeygi A, Zarghami N. Levels of oxidative stress biomarkers in seminal plasma and their relationship with seminal parameters. BMC Clin Pathol 2007; 7: 6. [DOI:10.1186/1472-6890-7-6]
39. Shamsi MB, Venkatesh S, Tanwar M, Talwar P, Sharma RK, Dhawan A, et al. DNA integrity and semen quality in men with low seminal antioxidant levels. Mutat Res 2009; 665: 29-36. [DOI:10.1016/j.mrfmmm.2009.02.017]
40. Branco CS, Garcez ME, Pasqualotto FF, Erdtman B, Salvador M. Resveratrol and ascorbic acid prevent DNA damage induced by cryopreservation in human semen. Cryobiology 2010; 60: 235-237. [DOI:10.1016/j.cryobiol.2009.10.012]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb